Disease Modelling and Drug Discovery in Neurological Disorders Zameel Cader, Director and Principal Scientist, IMI StemBANCC, University of Oxford, speaking at Stem Cells in Drug Discovery.
Cardiac iPSCs for Drug Discovery Joseph Wu, Director, Stanford Cardiovascular Institute, speaking at Stem Cells in Drug Discovery.
Novel Technology Approaches for Capture and Characterization of Circulating Tumor Cells Henry Lin,Graduate Student, University of California, speaking at CellTech 2013.
A Novel Vertically-Integrated Platform for the Discovery and Molecular Characterization of Lung Cancer Stem Cells Raj Batra, University of California Los Angeles, speaking at Diagnostics & Biomarkers 2015.
Phenotypic Profiling in a Physiologically Relevant Cell System Mohanraj Dhanabal, EMD Serono Inc, speaking at Drug Discovery and Development 2014
iPS-based Automated Drug Screening: From Human iPS to Midbrain Dopaminergic Neurons Jan Bruder, Max Planck Institute Münster, speaking at Advances in Automation & Robotics 2014
Detection and Characterization of Viable Circulating Tumor Cells Catherine Alix-Panabières, University Medical Center of Montpellier, speaking at Advances in Cellular Assays & Cell Culture 2014
A Potentially Scalable Method for the Harvesting of hMSCs from Microcarriers: Initial Results Qasim Rafiq, Loughbrough University, speaking at Advances in Cellular Assays & Cell Culture 2014
Cell culture automation: the stem challenge Glyn Stacey, National Institute for Biological Standards and Control speaking at Advances in Automation & Robotics 2014
In-vivo Single Cell Transcript Analyses for Systems Modelling Philip Day, Manchester University, speaking at Advances in qPCR & dPCR 2014.